FPF
SCLN

FNY Partners Fund’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

FNY Partners Fund’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-335,900
Closed -$3.76M – 707
2017
Q3 		$3.76M Buy
335,900
+327,900
+4,099% +$3.62M 0.64% 34
2017
Q2 		$88K Buy
+8,000
New +$80K 0.02% 219

FNY Partners Fund's SCLN Position: Q4 2017 in Review

FNY Partners Fund sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 335,900 shares — an estimated $3.76M sold.

FNY Partners Fund first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $3.76M in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • FNY Partners Fund reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • FNY Partners Fund sold 335,900 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $3.76M.
  • FNY Partners Fund first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • FNY Partners Fund's Sciclone Pharmaceuticals Inc position peaked at $3.76M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.